Literature DB >> 25532900

[Adaptive immune response and associated trigger factors in atopic dermatitis].

A Heratizadeh1, T Werfel, L M Rösner.   

Abstract

Due to a broad variety of extrinsic trigger factors, patients with atopic dermatitis (AD) are characterized by complex response mechanisms of the adaptive immune system. Notably, skin colonization with Staphylococcus aureus seems to be of particular interest since not only exotoxins, but also other proteins of S. aureus can induce specific humoral and cellular immune responses which partially also correlate with the severity of AD. In a subgroup of AD patients Malassezia species induce specific IgE- and T cell-responses which has been demonstrated by atopy patch tests. Moreover, Mala s 13 is characterized by high cross-reactivity to the human corresponding protein (thioredoxin). Induction of a potential autoallergy due to molecular mimicry seems therefore to be relevant for Malassezia-sensitized AD patients. In addition, sensitization mechanisms to autoallergens aside from cross-reactivity are under current investigation. Regarding inhalant allergens, research projects are in progress with the aim to elucidate allergen-specific immune response mechanisms in more depth. For grass-pollen allergens a flare-up of AD following controlled exposure has been observed while for house dust mite-allergens a polarization towards Th2 and Th2/Th17 T cell phenotypes can be observed. These and further findings might finally contribute to the development of specific and effective treatments for aeroallergen-sensitized AD patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25532900     DOI: 10.1007/s00105-014-3559-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  61 in total

1.  The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis.

Authors:  A Heratizadeh; I Mittermann; H Balaji; K Wichmann; M Niebuhr; R Valenta; T Werfel
Journal:  Br J Dermatol       Date:  2011-02       Impact factor: 9.302

2.  Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

Authors:  Louisa K James; Mohamed H Shamji; Samantha M Walker; Duncan R Wilson; Petra A Wachholz; James N Francis; Mikila R Jacobson; Ian Kimber; Stephen J Till; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

3.  Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.

Authors:  Christian Möbs; Henrik Ipsen; Lea Mayer; Caroline Slotosch; Arnd Petersen; Peter A Würtzen; Michael Hertl; Wolfgang Pfützner
Journal:  J Allergy Clin Immunol       Date:  2012-09-27       Impact factor: 10.793

4.  Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains.

Authors:  P H Hoeger; W Lenz; A Boutonnier; J M Fournier
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

5.  Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23).

Authors:  O Schulz; P Laing; H F Sewell; F Shakib
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

6.  Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity.

Authors:  Andreas Sonesson; Jacek Bartosik; Julie Christiansen; Ingrid Roscher; Fredrik Nilsson; Artur Schmidtchen; Ove Bäck
Journal:  Acta Derm Venereol       Date:  2013-05       Impact factor: 4.437

7.  Thioredoxin in human and experimental sepsis.

Authors:  Stefan Hofer; Claudia Rosenhagen; Hajime Nakamura; Junji Yodoi; Christian Bopp; Johannes B Zimmermann; Meike Goebel; Peter Schemmer; Kartrin Hoffmann; Klaus Schulze-Osthoff; Raoul Breitkreutz; Markus A Weigand
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

Review 8.  Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jung Min Bae; Yoon Young Choi; Chang Ook Park; Kee Yang Chung; Kwang Hoon Lee
Journal:  J Allergy Clin Immunol       Date:  2013-05-03       Impact factor: 10.793

9.  Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.

Authors:  Margarete Niebuhr; Uwe Mai; Alexander Kapp; Thomas Werfel
Journal:  Exp Dermatol       Date:  2008-06-14       Impact factor: 3.960

10.  Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Nadia Torres-Chinn; Wolfgang Pfützner; Christian Möbs; Stephen R Durham; Stephen J Till; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2013-12-25       Impact factor: 10.793

View more
  1 in total

Review 1.  [Topical therapy for atopic eczema].

Authors:  M Knop; A Gürtler; A Heratizadeh; N Aszodi; Th Werfel; A Wollenberg
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.